V A Gorbunova - JoVE Visualize

Showing results (31-40 of 45) with videos related to

Pageof 5

Sort By:

Terapevticheskii Arkhiv|January 1, 1996

[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients]N I Perevodchikova, M A Volkova, V A Gorbunova, et al.

Advances in Gerontology = Uspekhi Gerontologii|May 9, 2006

[Study on efficacy and toxicity of new combined regimen "taxoter + cisplatin + 5-fluorouracil" in disseminated and locally-spread stomach cancer. Comparative analysis of tolerance and efficacy in patients younger and older than 65 years]N S Besova, N F Orel, T A Borisova, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 20, 2014

[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin]S V Khokhlova, M V Cherkasova, N F Orel, et al.

Bulletin of Experimental Biology and Medicine|January 5, 2001

The use of 1H-NMR spectroscopy for predicting the efficiency of neoadjuvant chemotherapy of breast cancerN A Semenova, I Y Dydykina, L Y Dederer, et al.

European Journal of Cancer (Oxford, England : 1990)|July 15, 2004

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.

Bulletin of Experimental Biology and Medicine|February 15, 2001

Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivativesN V Lyubimova, S V Topchieva, S G Averinova, et al.

Neoplasma|January 1, 1987

Comparative evaluation of two administration schedules of cis-dichlorodiammineplatinum (DDP) in ovarian and head and neck cancers: a CMEA chemotherapy group studyZ Mechl, S Kerpel-Fronius, A Decker, et al.

Voprosy Onkologii|July 19, 2014

[Chemoradiotherapy for locally advanced cervical cancer]I Ia Bazaeva, V A Gorbunova, O A Kravets, et al.

Lung Cancer (Amsterdam, Netherlands)|September 15, 2001

Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of visionA V Bazhin, O N Shifrina, M S Savchenko, et al.

Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:

Pageof 5

Terapevticheskii Arkhiv|January 1, 1996

[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients]N I Perevodchikova, M A Volkova, V A Gorbunova, et al.

Advances in Gerontology = Uspekhi Gerontologii|May 9, 2006

[Study on efficacy and toxicity of new combined regimen "taxoter + cisplatin + 5-fluorouracil" in disseminated and locally-spread stomach cancer. Comparative analysis of tolerance and efficacy in patients younger and older than 65 years]N S Besova, N F Orel, T A Borisova, et al.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 20, 2014

[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin]S V Khokhlova, M V Cherkasova, N F Orel, et al.

Bulletin of Experimental Biology and Medicine|January 5, 2001

The use of 1H-NMR spectroscopy for predicting the efficiency of neoadjuvant chemotherapy of breast cancerN A Semenova, I Y Dydykina, L Y Dederer, et al.

European Journal of Cancer (Oxford, England : 1990)|July 15, 2004

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.

Bulletin of Experimental Biology and Medicine|February 15, 2001

Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivativesN V Lyubimova, S V Topchieva, S G Averinova, et al.

Neoplasma|January 1, 1987

Comparative evaluation of two administration schedules of cis-dichlorodiammineplatinum (DDP) in ovarian and head and neck cancers: a CMEA chemotherapy group studyZ Mechl, S Kerpel-Fronius, A Decker, et al.

Voprosy Onkologii|July 19, 2014

[Chemoradiotherapy for locally advanced cervical cancer]I Ia Bazaeva, V A Gorbunova, O A Kravets, et al.

Lung Cancer (Amsterdam, Netherlands)|September 15, 2001

Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of visionA V Bazhin, O N Shifrina, M S Savchenko, et al.

Pageof 5